Global X Uranium ETF (URA) fell 6.6% on October 30, 2026 to $33.38, a new 52-week low and 20.1% below its October 6 peak. The news flow does not explain the drop, and the fund trails the S&P 500 by 17.0% over 50 days. The weekly and daily trends both point down, so the balance of evidence leans negative with medium conviction. The oversold condition is the main argument against that view.
Why it matters
There is no single headline behind today's fall. The most recent uranium and nuclear news is, if anything, constructive. The Tennessee Valley Authority became the first U.S. utility to receive a construction permit for the BWRX-300 small modular reactor, PR Newswire reported. Polish investors are also backing a small-reactor venture, Bloomberg said. Miner items such as a high-grade Argentine assay and the enCore Energy share distribution of Verdera Energy are company-level or mechanical events. None of them would justify a 6.55% one-day drop in a diversified basket.
The price action says the market was already moving against the theme before today. URA peaked at $41.80 on October 6, the same day as the Jaguar Uranium assay release, and has lost about a fifth since. It is down 16.2% over one month, 40.8% over six months and 21.9% year to date. Today's fall came on volume 33.8% below the 20-day average. That looks more like steady selling than a rush for the exits, and it means the slide has not yet shown the kind of heavy-volume flush that often marks an exhaustion low.
The broad market explains little of this. Over five days URA lost 2.14% against 0.58% for SPY, and today it fell 6.55% against 1.79%. No sector ETF comparison is available, and the news does not say which holdings drove the move or whether fund flows played a part. SPY is up 10.8% this year while URA is down 21.9%, so the pressure is specific to uranium and nuclear-linked names.
The argument about the theme runs through AI power demand. The bearish case is that the AI buildout is running short of capital: Forbes points to stalling IPOs, rising borrowing costs and record hyperscaler credit default swap spreads. The Financial Times shows how large the spending is: Anthropic's prospectus plans $518bn of cloud and infrastructure spending ahead of a November listing. The supportive case is that reactor permitting is moving forward, and Forbes argues that Western governments are spending heavily on critical-minerals supply outside China. That article is about rare earths, not uranium, so it is only indirect support. There are no analyst price targets or earnings dates to measure URA against, because it is a fund. Its price has to be judged by trend and by relative performance.
What the evidence says
The long-term thesis is weakened and the price is in a decline phase. URA sits below its 40-week average. The 50-day average at $40.83 is below the 200-day at $47.11. The fund is 46.0% under its 52-week high of $61.81 and is trading at the 52-week low. It trails SPY by 17.0% over 50 days and by 32.1% over 200 days. The theme has not been repudiated by the news, but the market has stopped paying for it.
For the next two to six weeks, the balance of evidence leans negative. Conviction is medium, 2 of 4 points. The daily trend runs with the weekly downtrend, and URA is lagging the S&P 500. Those two factors carry the reading. Conviction is not higher because the other two points are missing, and because the fund is stretched to the downside.
The strongest case against is the oversold condition. The 14-day RSI is 30.56. Across 151 past cases of a one-day drop of more than 5%, the price was higher a month later 70.9% of the time, with a median one-month move of 5.38%. The typical month is higher 61.8% of the time, so the bounce tendency is only modestly above normal. A bounce is plausible, but it would be a rally inside a downtrend until price recovers the levels below. That is why conviction stops at medium.
Levels that matter
The structure sits below $35.00, a round number where sellers have shown up on rallies. With the weekly trend down, a rebound that stalls near $35.00 would fit the pattern. Above it lie $40.00 and the 50-day average at $40.83. The weekly downtrend would end only above $42.47, a swing zone that also sits just beneath the October 6 peak area.
The downside breakout level is a daily close below $30.00, a round number. From there the nearest target is $25.00. A move would be wrong above $35.33, which is $35.00 plus a quarter of the 14-day ATR of $1.31. That gives a reward-to-risk of 0.9, so the math does not reach 3 to 1. It would take a much deeper target than $25.00 or a stop much tighter than $35.33 to get there, and neither is on the current map.
What would change the picture
A weekly close above $42.47 would be the first sign that buyers are back and the downtrend has ended. The non-price fact that would most likely do it is evidence that the financing behind AI-related power demand is holding up. Easing credit stress among AI borrowers, or a completed Anthropic listing that goes through smoothly, would remove the main argument against the theme. A rally that fails short of $35.00 would not change anything.
What to watch
- The $35.00 area: whether a rebound from the oversold condition reaches it and stalls, or clears it.
- A daily close below $30.00, which would open the path to $25.00.
- AI funding conditions, including the planned November Anthropic listing, and credit spreads for AI-related borrowers.
- Fed expectations and bond yields. Yields eased on September 30 after Morningstar reported that Fed rate-hike expectations had been scaled back. A reversal would pressure long-duration themes like this one.
- Further SMR permitting and utility announcements after the TVA permit.
- No fund flow or holdings data is available in the news. No earnings date applies to the fund, though holdings' earnings can move the basket.
- The broad market: a deeper S&P 500 pullback would show whether URA's weakness is theme-specific or a wider retreat. SPY is down 0.93% over one month.